
Ken Jones appointed head of Astellas Europe
pharmafile | April 13, 2011 | Appointment | |ย ย Astellas, Ken Jonesย
Astellas has appointed Ken Jones as its president and chief executive in Europe.
Jones had been the chief operating officer for Astellas Pharma Europe since July 2007 and succeeds Masao Yoshida.
Yoshida has now been appointed as president and chief executive of the US subsidiary of Astellas.
Jones said: โI am delighted and honoured to be taking on this new role and I look forward to building on Astellas Pharma Europe’s considerable achievements.
โIn spite of the tough market conditions that the industry is facing, weโre in a strong position and have clear strategies for growth through expanding and developing our core franchises.โ
Jones joined the company (then Yamanouchi) in January 2003 as VP of European marketing and then in 2005, when Fujisawa and Yamanouchi merged to produce Astellas, was promoted to Senior VP of sales, marketing and medical.
Previously, Jones spent 16 years with Allergan holding senior international marketing positions across the US, Europe and Japan.
His career began as a management associate with SmithKline Beckman in Philadelphia, followed by senior roles in Allergan.
Related Content

Astellas and Elpiscience enter collaboration for novel bispecific macrophage engager
Elpiscience Biopharma and Astellas Pharma have announced that they have entered into a research collaboration …

EMA accepts Astellasโ MAA for Zolbetuximab
Astellas Pharma has announced that the European Medicines Agency (EMA) has accepted the companyโs marketing …

Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders
Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have …






